Amarin (AMRN) Up 7% on Intellectual Property Wins in Europe
https://www.zacks.com/stock/news/2250719/amarin-amrn-up-7-on-intellectual-property-wins-in-europe?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2250719
Apr 04, 2024 - Amarin (AMRN) secures a new patent for Vazkepa in Europe, which extends its exclusivity for eight more years. It achieves success in defending another patent on the drug against third parties.
0
Amarin Plc (AMRN) Q4 2023 Earnings Call Transcript
https://www.fool.com/earnings/call-transcripts/2024/02/29/amarin-plc-amrn-q4-2023-earnings-call-transcript/?source=iedfolrf0000001
Feb 29, 2024 - AMRN earnings call for the period ending December 31, 2023.
0
Can Low Occupancy Rate Affect Select Medical (SEM) Q4 Earnings?
https://www.zacks.com/stock/news/2228685/can-low-occupancy-rate-affect-select-medical-sem-q4-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2228685
Feb 20, 2024 - Select Medical's (SEM) fourth-quarter results are likely to reflect growing visits in Outpatient Rehabilitation and Concentra.
0